Kamada (KMDA) Interest Coverage Ratio (2012 - 2026)
Kamada (KMDA) posted quarterly Interest Coverage Ratio of 36.98 for Q1 2026, down 191.1% year-on-year from 40.6 in Q1 2025, and down 13.59% on a QoQ basis from 32.56 in Q4 2025.
Kamada (KMDA) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Interest Coverage Ratio for 15 consecutive years, with 36.98 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio fell 191.1% year-over-year to 36.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 43679.03 (down 2424.49% YoY) and the FY2025 annual result came in at 30.36, changed 0.06% from the prior year.
- Interest Coverage Ratio fell to 36.98 in Q1 2026 per KMDA's latest filing, from 32.56 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for KMDA reached as high as 12142.18 in Q3 2022 and fell as low as 91004.77 in Q2 2025.
- A 5-year average of 4849.55 and a median of 12.14 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 92023.51% — and 2025, when it sank 234066.17%.
- Year by year, Interest Coverage Ratio stood at 12.14 in 2022, then plunged by 189.47% to 35.14 in 2023, then sank by 45.21% to 51.03 in 2024, then soared by 36.19% to 32.56 in 2025, then declined by 13.59% to 36.98 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 36.98, 32.56, and 55.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -36.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.98 |
| Dec 31, 2025 | -32.56 |
| Sep 30, 2025 | 55.75 |
| Jun 30, 2025 | -91,004.77 |
| Mar 31, 2025 | 40.60 |
| Dec 31, 2024 | -51.03 |
| Sep 30, 2024 | -58.65 |
| Jun 30, 2024 | 38.90 |
| Mar 31, 2024 | 25.40 |
| Dec 31, 2023 | -35.14 |
| Sep 30, 2023 | -4,074.63 |
| Jun 30, 2023 | -3.62 |
| Mar 31, 2023 | 578.00 |
| Dec 31, 2022 | -12.14 |
| Sep 30, 2022 | 12,142.18 |
| Jun 30, 2022 | -12.33 |
| Mar 31, 2022 | -1.27 |
| Dec 31, 2021 | 3.00 |
| Sep 30, 2021 | 13.18 |
| Jun 30, 2021 | 16.60 |